Literature DB >> 27869923

Cross-sectional study on case fatality rate due to hantavirus infection in Goiás State, Brazil, 2007-2013.

Hélio Ranes de Menezes1, Marcos Lázaro Moreli1, Ana Luiza Lima Sousa2, Vivaldo Gomes da Costa1.   

Abstract

OBJECTIVE: to describe the epidemiological and clinical profile of hantavirus infection and to analyze factors associated with case-fatality in Goiás, Brazil.
METHODS: this was a cross-sectional study on case fatality due to hantavirus infection from 2007 to 2013 using data from the Notifiable Diseases Information System (SINAN) for Goiás State. Logistic regression analysis was performed to estimate odds ratios (OR) with 95% confidence intervals (95%CI).
RESULTS: 1,171 suspected cases were reported, of which 73 (6.2%) were confirmed. Among the confirmed cases, greater frequency was found among males (n=50), fever was the most common symptom (n=70), and there was a high proportion of hospitalization (n=68). The case-fatality rate was 57.5% . The following factors were associated with death: acute respiratory failure (ARF) (OR=3.6; 95%CI 1.2;10.6), hemoconcentration (OR=3.3; 95%CI 1.1;7.9) and not using a mechanical ventilator (OR=3.4; 95%CI 1.3;9.1). After adjustment, the ARF was still associated with death (OR=3.4; 95%CI 1.0;11.6).
CONCLUSION: the case-fatality rate was high, primarily associated with respiratory failure.

Entities:  

Mesh:

Year:  2016        PMID: 27869923     DOI: 10.5123/S1679-49742016000300008

Source DB:  PubMed          Journal:  Epidemiol Serv Saude        ISSN: 1679-4974


  1 in total

1.  Silent Orthohantavirus Circulation Among Humans and Small Mammals from Central Minas Gerais, Brazil.

Authors:  Carolina Dourado Amaral; Galileu Barbosa Costa; William Marciel de Souza; Pedro Augusto Alves; Iara Apolinário Borges; Aline Lavado Tolardo; Marília Farignoli Romeiro; Betânia Paiva Drumond; Jônatas Santos Abrahão; Erna Geessien Kroon; Adriano Pereira Paglia; Luiz Tadeu Moraes Figueiredo; Giliane de Souza Trindade
Journal:  Ecohealth       Date:  2018-08-13       Impact factor: 3.184

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.